Summers, R. L., Pasaje, C. F. A., Pisco, J. P., Striepen, J., Luth, M. R., Kumpornsin, K., Carpenter, E. F., Munro, J. T., Lin, D., Plater, A., Punekar, A. S., Shepherd, A. M., Shepherd, S. M., Vanaerschot, M., Murithi, J. M., Rubiano, K., Akidil, A., Ottilie, S., Mittal, N., Dilmore, A. H., Won, M., Mandt, R. E., McGowen, K., Owen, E., Walpole, C., Llinás, M., Lee, M. C., Winzeler, E. A., Fidock, D. A., Gilbert, I. H., Wirth, D. F., Niles, J. C., Baragaña, B., & Lukens, A. K. (2022). chemogenomics identifies acetyl-coenzyme A synthetase as a target for malaria treatment and prevention. Cell chemical biology, 29(2), 191–201.e8. http://access.bl.uk/ark:/81055/vdc_100152258526.0x000004